The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through Gαi-protein signalling
- 26 June 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 20 (10), 1369-1377
- https://doi.org/10.1097/01.aids.0000233570.51899.e2
Abstract
The intensity of replication of CCR5-using HIV-1 strains is highly dependent on the number of CCR5 molecules on the surface of CD4-positive T cells. The molecular mechanisms responsible for this phenomenon remained so far unclear. As CCR5 co-receptors are coupled to G alpha i and G alpha q proteins, we tested the hypothesis that the activation triggered through these proteins secondary to the interaction between the viral envelope and CCR5 could account for the effect of the level of CCR5 expression on HIV-1 production. We transduced the wild-type or a G-protein signalling-defective CCR5 gene into CD4/CCR5 HOS cells and peripheral blood mononuclear cells. The effect on cell activation in presence of a CCR5-binding chemokine and on HIV infection was monitored by measuring calcium mobilization and p24 antigen production, respectively. The role of G alpha i protein signalling was tested by adding pertussis toxin to the cell cultures or by transfecting small interfering (si) RNAs into the HOS cells. The over-expression of the wild-type form, but not of a G-protein signalling-defective form of CCR5, on the surface of CCR5 expressing peripheral blood mononuclear cells markedly increased their infectability. In addition, both pertussis toxin and G alpha i 1-specific siRNA drastically inhibited R5 infection. The signalling through G alpha i-protein induced upon R5 virion binding to CCR5 is responsible for the difference in HIV-1 infectability between CD4-positive T cells expressing low or high levels of cell surface CCR5 density. This observation sheds new light on the physiopathology of HIV infection, and opens new therapeutic opportunities targeting G alpha i signalling.Keywords
This publication has 18 references indexed in Scilit:
- G-Protein Signaling Triggered by R5 Human Immunodeficiency Virus Type 1 Increases Virus Replication Efficiency in Primary T LymphocytesJournal of Virology, 2005
- Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell FusionJournal of Virology, 2004
- The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the p6 Protein of HIV-1Published by Elsevier BV ,2004
- Relationship Between CCR5 Density and Viral Load After Discontinuation of Antiretroviral TherapyJAMA, 2004
- Response to Treatment and Disease Progression Linked to CD4+T Cell Surface CC Chemokine Receptor 5 Density in Human Immunodeficiency Virus Type 1 Vertical InfectionThe Journal of Infectious Diseases, 2002
- Preferential Attachment of HIV Particles to Activated and CD45RO+CD4+T CellsAIDS Research and Human Retroviruses, 2002
- CD4+T Cell Surface CCR5 Density as a Determining Factor of Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 2000
- CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In VitroThe Journal of Experimental Medicine, 1997
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990